Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 3224 | 245 | 0.9716 | 0.9734 | 0.0760 | 0.0805 |
MZ7-mel | Vemurafenib | Saracatinib | 0.000 | 3.160 | uM | 72 | hr | 3 | 1605 | 149 | 0.4749 | 0.9734 | 0.0928 | 0.0805 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 1917 | 95 | 0.5943 | 0.7294 | 0.0496 | 0.0484 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 2 | 2418 | 122 | 0.7489 | 0.7294 | 0.0505 | 0.0484 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.000 | uM | 72 | hr | 3 | 2714 | 123 | 0.8451 | 0.7294 | 0.0453 | 0.0484 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 1414 | 87 | 0.4328 | 0.7091 | 0.0615 | 0.0504 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 2523 | 106 | 0.7883 | 0.7091 | 0.0420 | 0.0504 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 0.316 | uM | 72 | hr | 3 | 2917 | 139 | 0.9061 | 0.7091 | 0.0477 | 0.0504 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 1 | 2405 | 95 | 0.7534 | 0.5199 | 0.0395 | 0.0507 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 2 | 1676 | 76 | 0.5219 | 0.5199 | 0.0453 | 0.0507 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 1.000 | uM | 72 | hr | 3 | 935 | 63 | 0.2844 | 0.5199 | 0.0674 | 0.0507 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 2740 | 133 | 0.8503 | 0.6154 | 0.0485 | 0.0443 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 2 | 2133 | 89 | 0.6667 | 0.6154 | 0.0417 | 0.0443 |
MZ7-mel | Vemurafenib | Saracatinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1054 | 45 | 0.3291 | 0.6154 | 0.0427 | 0.0443 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 1 | 1177 | 92 | 0.3539 | 0.5276 | 0.0782 | 0.0734 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 2 | 1811 | 126 | 0.5496 | 0.5276 | 0.0696 | 0.0734 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 0.000 | uM | 72 | hr | 3 | 2246 | 163 | 0.6794 | 0.5276 | 0.0726 | 0.0734 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 1274 | 83 | 0.3885 | 0.4386 | 0.0651 | 0.0724 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 2 | 1259 | 96 | 0.3793 | 0.4386 | 0.0763 | 0.0724 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 0.316 | uM | 72 | hr | 3 | 1818 | 138 | 0.5479 | 0.4386 | 0.0759 | 0.0724 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 2062 | 135 | 0.6285 | 0.4197 | 0.0655 | 0.0627 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 2 | 1409 | 72 | 0.4361 | 0.4197 | 0.0511 | 0.0627 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 642 | 46 | 0.1944 | 0.4197 | 0.0717 | 0.0627 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1603 | 97 | 0.4912 | 0.3835 | 0.0605 | 0.0574 |
MZ7-mel | Vemurafenib | Saracatinib | 0.316 | 3.160 | uM | 72 | hr | 2 | 1453 | 82 | 0.4472 | 0.3835 | 0.0564 | 0.0574 |